Drug intelligence / Profile preview

Hyal-Plus (Elliott Labs)

Development stage
Unknown
Lead developer
Elliott Labs
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Hyal-Plus is an oral nutraceutical combination product developed and marketed by Elliott Labs for the management of joint disorders, including osteoarthritis, rheumatoid arthritis, facet arthropathy, and ankylosing spondylitis. Formulated as a tablet, it contains a synergistic blend of Rosehip extract, Boswellia serrata extract, Vitamin C (ascorbic acid), and piperine. Boswellia serrata extract acts as an allosteric inhibitor of arachidonate 5-lipoxygenase (ALOX5), reducing the synthesis of inflammatory leukotrienes. Rosehip extract contains anti-inflammatory galactolipids (such as GOPO) that inhibit leukocyte chemotaxis and cytokine secretion, thereby protecting cartilage from degradation. Vitamin C serves as an essential cofactor for prolyl 4-hydroxylase, promoting collagen synthesis and cartilage repair. Piperine acts as a bioenhancer by inhibiting drug-metabolizing enzymes (such as CYP3A4) and efflux transporters (such as P-glycoprotein/ABCB1), which increases the absorption and bioavailability of the other active ingredients while also providing mild anti-inflammatory benefits.

Brand names
HYAL PLUSHyal-Plus
Other names
Rosehip / Boswellia / Vitamin C / PiperineRosehip extract + Boswellia serrata + ascorbic acid + piperine
02

Targets

ABCB1 (P-glycoprotein)P4H (Prolyl 4-hydroxylase subunit alpha-3)CYP3A4 (Cytochrome P450 3A4)ALOX5 (Arachidonate 5-lipoxygenase)

Beyond the preview

Go deeper on Hyal-Plus (Elliott Labs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hyal-Plus (Elliott Labs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call